Insight Analysis from Real-World Data
We are a team of specialists that share a passion for finding solutions for our customers, together with inventiveness and technical expertise to provide high-quality outcomes.
Our company is made up of a group of consultants that specialize in the healthcare business. Our personnel have vast expertise managing and comprehending the access and high-specialty markets of the public and private healthcare provider organizations, not just in Mexico, but across LATAM as well.
Mision
To be the premier provider of scientific research and health economics consulting services. Utilizing modern technology, we will convey the outcomes of our services in an innovative and effective manner to our end consumers.
Due to the mix of innovation, dynamic problem-solving, and first-rate scientific underpinnings, we can provide the optimal solution for achieving the sales and positioning objectives.
Vision
Provide high-quality goods and services to meet the demands of the healthcare sector and pharmaceutical companies. By combining the efforts of experts in research, health economics, and market access, we can provide complete answers to the challenges of modern competition and product/service positioning in the healthcare industry.
Our Team
Our staff has over 10 years of integration and expertise in medicine, health economics, market access, statistics, and information technology. We also use scientific and clinical colleagues and advisers for specialized initiatives.
Estimatio gives customers full-service consultancy.
Medical Staff
Provides all research with support and clinical validity. In the early phases of the development of our services, they play a crucial role in establishing patient care algorithms and essential clinical data.
HEOR & Market Access
Responsible for resolving issues with healthcare and pharmaceutical industry decision-making. Its primary function is to conduct Economic and Impact Evaluation studies, which may be used to develop and implement market positioning strategies.
Strategic Solutions
Its purpose is to locate promising markets and provide original approaches to entering them. Create strategies for getting work done that minimize wasteful use of time and resources, always with the end goal of providing the best possible service to our clients.
Departments & Services
Department of Research Development & Business Analysis (RD & BA Department)
When it comes to providing our clients with the data analysis resources and support, they need to make informed business decisions, our RD & BA department really excels.
Services include strategic planning, data collection and analysis, and data presentation and interpretation are also provided.
To uncover latent dynamics, patterns, and trends in the data we gather, we use an array of analytical techniques. To better understand the dynamics of healthcare delivery inside institutions, to promote product uptake, and to optimize returns during the product’s first rollout, our customers benefit from our multi-level market study.
Our services are:
- - Models of the dynamics of medical attention in healthcare institutions.
- - Predictive analysis and time series of databases.
- - Systematic Review, Meta-Analyses & Network Meta-Analyses.
- - Conceptual and analytical models
- - In-depth interview addressed to physicians and opinion leaders
- - Dynamic Dashboards using online and/or mobile application user interfaces.
- - Preparation of papers, Clinical Practice Guidelines (CPG), and peer-reviewed findings communication (medical writing).
- - Ad hoc services.
Department of Market Access & HEOR
Research and analysis are carried out by this section to determine the efficacy and value of healthcare treatments such as drugs, biologicals treatments, vaccines , material and medical equipment, and healthcare services. In order to accomplish this goal, we conduct an analysis of the data collected from clinical trials, evidence gathered from the real world, and other data sources derived from the public and private healthcare sectors.
Our services are:
- - Systematic Reviews, Meta-analysis & Network Meta-analysis.
- - Economic analysis: cost-effectiveness, cost-minimization, budgetary impact, among others.
- - Price calculators for sales force and product managers.
- - Price and penetration analysis.
- - Preparation of a dossier for inclusion in the national compendium of health supplies and institutional charts (value dossier).
- - Regulatory concerns.
Publications
- - Luna-Casas G, et al. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines. Hum Vaccin Immunother. 2019;15(6):1251-1259
- - Guzman-Holst A, et al. Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis. Vaccine 2021 Apr 15;39(16):2311-2318.
- - Guzman-Holst A, et al. Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study. PLoS One 2022 May 18;17(5):e0268469.
- - Sanchez-Gonzalez G, et al. Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico. PLoS neglected tropical diseases 2016; 10(3):e0004528.
- - Valencia-Mendoza A, et al. Costo-efectividad de políticas para el tamizaje de cáncer de mama en México. Salud Pub Mex 2009; 51: suppl s296-s304.
- - Sánchez-González G, et al. Prediction ofdengue outbreaks in Mexico based on entomological, meteorological and demographic data. PLoS ONE 2017; 13(8): e0196047.
- - Sánchez-González G, et al. A beta-complex statistical four body contact potential combined with a hydrogen bond statistical potential recognizes the correct native structure from protein decoy sets. Proteins 2013 Aug;81(8):1420-33.
- - González‐Robledo L, et al. Use of DNA sequencing for noncommunicable diseases in low‐income and middle‐income countries' primary care settings: A narrative synthesis. Int J Health Plann Mgmt. 2018;1–26
- - Sánchez-González, G. (2016). The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus. HIV Medicine, 17(9), 674–682.
- - Sánchez-González G, et al. Probability of consolidation constrains novel serotype emergence in dengue fever virus. PLoS ONE 16(4): e0248765.
- - A. Schaum, et al. Modeling the spreading of dengue using a mixed population model. IFAC-PapersOnLine Volume 55, Issue 20, 2022, Pages 582-587.
- - López Vázquez PC, et al. Stochastic epidemiological model: Simulations of the SARS-CoV-2 spreading in Mexico. PLoS One 2022 (9): e0275216.
- - Godoy-Lozano E, et al. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal centerindependent B cell response. Genome Medicine (2016) 8:23.
Contact Us
Have a question or are you curious about our services?
Contact us at:
Phone:
+52 55 4534 9848
Email:
contacto@estimatiosc.com
EN_US 
ES_MX